 | Up a level |
De Jong, W.H. and Borges, T. and Ion, R.M. and Panagiotakos , D. and Testai, E. and Vermeire, T. and Scott, M. and Samaras, T. and Proykova, A. and Kraetke, R. and Hoet, P. and Bertollini, R. and Duarte-Davidson, R. and Slama, R. and de Voogt, P. and Kraetke, R. and Proykova, A. and Vighi, M. (2020) Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties. Regulatory Toxicology and pharmacology, 111. p. 104546.
